Home > Healthcare > Analytical Instruments > Molecular Analysis > Protein A Resins Market

Protein A Resins Market Trends

Report ID: GMI1146
Published Date: Feb 2020
Report Format: PDF

Download Free Sample

Protein A Resins Market Trends

Growing investment in synthetic biology and increasing focus on drug development by biotechnology and pharmaceutical companies will propel the industry growth. Biopharmaceutical industry are extensively using protein engineered products in their research activities to develop broad range of protein-based drugs. Therefore, rising use of chromatography in drug discovery and research industry will propel the market growth over the forecasted time period.

Increasing demand of monoclonal antibodies (mAb) globally for the better treatment of chronic diseases and increasing number of pharmaceutical and biotechnology companies will boost the overall protein A resins industry growth. With better treatment options with the help of immunotherapy, the adoption will also surge. However, high cost associated with product may hinder market opportunities during the analysis timeframe.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of protein A resins exceeded USD 600 million in 2019.

The industry share of protein A resins is predicted to grow at 8.9% CAGR during 2020-2026.

According to GMI report, the North America protein A resins will witness around 9% CAGR during 2020-2026.

Increasing usage of protein A resins in antibody purification procedure along with rising adoption of chromatographic techniques for identification of biochemicals will positively impact industry demand.

The biopharmaceutical companies segment accounted for over USD 453 million market size in 2019, says a GMI report.

Some of the major companies in protein A resins industry include GE Healthcare, Thermo Fisher Scientific, EMD Millipore, and Bio-Rad Laboratories, etc.